Beecher HK. Ethics and clinical research. N Engl J Med.1966;274:1354-1360.
Rothman DJ. Strangers at the Bedside . New York, NY: Basic Books; 1991:70-84.
Faden R, Beauchamp TL. A History and Theory of Informed Consent . New York, NY: Oxford University Press; 1986:200-232.
Schwartz J. Company faulted in fatal drug trials. Washington Post.December 10, 1993:A4.
McGinley L. FDA finds Lilly, others violated rules in tests of hepatitis drug that
killed 5. Wall Street Journal.May 16, 1994:B6.
Office for Protection From Research Risks. Evaluation of Human Subject Protections in Schizophrenia Research
Conducted by the University of California, Los Angeles . Rockville, Md: Office for Protection From Risks, National Institutes
of Health; 1994.
Haimowitz S, Delano SJ, Oldham JM. Uninformed decisionmaking: the case of surrogate research consent. Hastings Cent Rep.1997;27(6):9-16.
Stelfox HT, Chua G, O'Rourke K, Detsky AS. Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med.1998;338:101-106.
Rules and Regulations . Rockville, Md: US Dept Health and Human Services; 1991. Publication
Advisory Committee on Human Radiation Experiments. Final Report . Washington, DC: US Government Printing Office; 1995:797-798.
Miller FG, Caplan AL, Fletcher JC. Dealing with Dolly: inside the National Bioethics Advisory Commission. Health Affairs (Millwood).1998;17:264-267.
Lind SE. Financial issues and incentives related to clinical research and innovative
therapies. In: Vanderpool HY, ed. The Ethics of Research Involving Human
Subjects . Frederick, Md: University Publishing Group; 1996:185-202.
Miller FG, Brody H. Professional integrity and physician-assisted death. Hastings Cent Rep.1995;25(3):8-17.
Reiser SJ. Human experimentation and the convergence of medical research and patient
care. In: Bernard Barber, ed. Medical Ethics and Social Change .
Philadelphia, Pa: American Academy of Political and Social Science; 1978.
Appelbaum PS, Roth LH, Lidz CW, Benson P, Winslade W. False hopes and best data: consent to research and the therapeutic
misconception. Hastings Cent Rep.1987;17(2):20-24.
Festinger LA. Theory of Cognitive Dissonance . Evanston, Ill: Row Peterson; 1957.
Lipsett MB. On the nature and ethics of phase I clinical trials of cancer chemotherapies. JAMA.1982;248:941-942.
Freedman B. The ethical analysis of clinical trials: new lessons for and from cancer
research. In: Vanderpool HY, ed. The Ethics of Research Involving Human
Subjects . Frederick, Md: University Publishing Group; 1996:319-338.
Carpenter WT, Schooler NR, Kane JM. The rationale and ethics of medication-free research in schizophrenia. Arch Gen Psychiatry.1997;54:401-407.
Schulz KF. Subverting randomization in controlled trials. JAMA.1995;274:1456-1458.
Katz J. Human experimentation and human rights. St Louis University Law Journal .1993;38:7-54.
Daugherty C, Ratain MJ, Grochowski E.
et al. Perceptions of cancer patients and their physicians involved in phase
I trials. J Clin Oncol .1995;13:1062-1072.
Kass NE, Sugarman J, Faden R, Schoch-Spana M. Trust: the fragile foundation of contemporary biomedical research. Hastings Cent Rep.1996;26(5):25-29.
Schwartz J. Final Report of the Attorney General\'s Research Working Group . Baltimore, Md: Office of the Maryland Attorney General; June 12,
Levine RJ. Ethics and Regulation of Clinical Research . 2nd ed. New Haven, Conn: Yale University Press; 1986:8-10.
Miller FG, Rosenstein DL. Psychiatric symptom-provoking studies: an ethical appraisal. Biol Psychiatry.1997;42:403-409.
Grinnell F. Ending of clinical research protocols: distinguishing therapy from
Shorter E. A History of Psychiatry . New York, NY: John Wiley & Sons; 1997:141-142.
Pellegrino ED, Thomasma DC. A Philosophical Basis of Medical Practice . New York, NY: Oxford University Press; 1981:151-152.
National Commission for the Protection of Human Subjects of Biomedical
and Behavioral Research.. The Belmont Report: Ethical Principles and Guidelines for Research
Involving Human Subjects . Washington, DC: US Government Printing Office; 1979.